| Identification | Back Directory | [Name]
Zinc, bis[(3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-(hydroxy-κO)-5-hydroxy-6-heptenoato-κO-]-, (T-4)- | [CAS]
953412-08-3 | [Synonyms]
Rosuvastatin zinc salt
Zinc, bis[(3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-(hydroxy-κO)-5-hydroxy-6-heptenoato-κO-]-, (T-4)- | [Molecular Formula]
C44H52F2N6O12S2Zn | [MOL File]
953412-08-3.mol | [Molecular Weight]
1024.43 |
| Hazard Information | Back Directory | [Uses]
Rosuvastatin zinc salt (Rosuvastatin zinc) is a zinc-containing form of Rosuvastatin (HY-17504A). Rosuvastatin is a HMG-CoA reductase inhibitor and can be used for atherosclerosis research[1]. | [References]
[1] Watanabe M, et al. Synthesis and biological activity of methanesulfonamide pyrimidine- and N-methanesulfonyl pyrrole-substituted 3,5-dihydroxy-6-heptenoates, a novel series of HMG-CoA reductase inhibitors. Bioorg Med Chem. 1997 Feb;5(2):437-44. DOI:10.1016/s0968-0896(96)00248-9 |
|
|